Q3 2025

Filed Apr 22, 2025 · 10-Q · 53 days after period end · 0001683168-25-002715

Q3 2025 · 10-Q

Revenue

$14.93K

−59.0% vs Q3 2024

Net Income

-$181.24K

N/M vs Q3 2024

EPS Diluted

-$0.00

N/M vs Q3 2024

Gross Profit-$4,465N/M

Operating Income

Same quarter

Metric	Q3 2025	Q3 2024	Q3 2023	Q3 2012
Revenue	$14.93K	$36.41K	$51.25K	$8.57M
Net Income	-$181.24K	-$209.19K	-$324.66K	-$1.24M
EPS Diluted	-$0.00	-$0.00	-$0.00	-$0.09

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Cannabis Bioscience International Holdings, Inc. · CIK 1411057 · Engraved from SEC EDGAR